• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

bone cancer

Medtronic headquarters
MedTech

Medtronic gets FDA OK for upgraded bone tumor ablation system

The OsteoCool 2.0 system delivers radiofrequency ablation to bone tumors, including cancer metastases and benign lesions such as osteoid osteoma.
Conor Hale Mar 4, 2024 11:00am
MA

Telix offers $33M to acquire Qsam and phase 1 bone cancer drug

Nov 14, 2023 8:20am
RefleXion Medical Scintix

FDA clears RefleXion's biology-guided radiotherapy tech

Feb 7, 2023 10:55am
Chad Moles chief science officer and co-founder of Humane Genomics working in his lab

3D-printing oncolytic viruses to treat rare cancers

Aug 27, 2021 10:45am
An illustration depicting how Umojas therapies work

Umoja aims immunotherapies at the clinic with $210M raise

Jun 15, 2021 7:00am
Breast Cancer Cells

Could Amgen's Xgeva boost immunotherapy in breast cancer?

Dec 14, 2020 9:10am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings